Skip to content
2000
Volume 22, Issue 6
  • ISSN: 1570-162X
  • E-ISSN: 1873-4251

Abstract

Extracellular Vesicles (EVs), more specifically exosomes (xEVs), have been associated with Diffuse Large B-cell Lymphoma (DLBCL). These xEVs contain a variety of biomolecules, such as proteins and nucleic acids (, microRNA, LncRNA, and DNA). The expressions of these vesicles in the setting of Human Immunodeficiency Virus (HIV) have been linked to disease progression. Studies have explored the use of EVs in more practical clinical settings. Several studies have found that biomolecules within xEVs can serve to detect disease progression. The biomolecule content within xEVs is useful in prognostication and has even been associated with mechanisms of resistance for some DLBCL treatment modalities. This review article explores the role of xEV biomolecule content in DLBCL progression in the context of HIV infection and its applied use in practical disease management.

Loading

Article metrics loading...

/content/journals/chr/10.2174/011570162X288575240821201433
2024-12-01
2025-05-04
Loading full text...

Full text loading...

References

  1. LauriniJ.A. PerryA.M. BoilesenE. DieboldJ. MacLennanK.A. Müller-HermelinkH.K. NathwaniB.N. ArmitageJ.O. WeisenburgerD.D. Classification of non-Hodgkin lymphoma in Central and South America: A review of 1028 cases.Blood2012120244795480110.1182/blood‑2012‑07‑44007323086753
    [Google Scholar]
  2. OforiK. BhagatG. RaiA.J. Exosomes and extracellular vesicles as liquid biopsy biomarkers in diffuse large B-cell lymphoma: Current state of the art and unmet clinical needs.Br. J. Clin. Pharmacol.202187228429410.1111/bcp.1461133080045
    [Google Scholar]
  3. SirsathN. SathyanarayananV. SettyG.B.K. ChannaviriappaL.K. NagendrappaL.K. DasappaL. Human Immunodeficiency Virus - associated lymphomas: A neglected domain.N. Am. J. Med. Sci.20135743243710.4103/1947‑2714.11577224020054
    [Google Scholar]
  4. CarboneA. VaccherE. GloghiniA. PantanowitzL. AbayomiA. de PaoliP. FranceschiS. Diagnosis and management of lymphomas and other cancers in HIV-infected patients.Nat. Rev. Clin. Oncol.201411422323810.1038/nrclinonc.2014.3124614140
    [Google Scholar]
  5. MaganganeP. SookhayiR. GovenderD. NaidooR. Determining protein biomarkers for DLBCL using FFPE tissues from HIV negative and HIV positive patients.J. Mol. Histol.201647656557710.1007/s10735‑016‑9695‑y27696080
    [Google Scholar]
  6. LiS. YoungK.H. MedeirosL.J. Diffuse large B-cell lymphoma.Pathology2018501748710.1016/j.pathol.2017.09.00629167021
    [Google Scholar]
  7. XueY. WangQ. HeX. Clear cell variant of diffuse large B-cell lymphoma: A case report and review of the literature.Int. J. Clin. Exp. Pathol.2015867594759926261675
    [Google Scholar]
  8. AnyanwuS.I. DohertyA. PowellM.D. ObialoC. HuangM.B. QuarshieA. MitchellC. BashirK. NewmanG.W. Detection of HIV-1 and human proteins in urinary extracellular vesicles from HIV+ patients.Adv. Virol.2018201811610.1155/2018/786341229721020
    [Google Scholar]
  9. DiasM.V.S. CostaC.S. daSilvaL.L.P. The ambiguous roles of extracellular vesicles in HIV replication and pathogenesis.Front. Microbiol.20189241110.3389/fmicb.2018.0241130364166
    [Google Scholar]
  10. TheryC. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current Protocol In Cell BiologyHoboken, New JerseyWiley200610.1002/0471143030.cb0322s30
    [Google Scholar]
  11. ColomboM. MoitaC. van NielG. KowalJ. VigneronJ. BenarochP. ManelN. MoitaL.F. ThéryC. RaposoG. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles.J. Cell Sci.2013126Pt 24jcs.12886810.1242/jcs.12886824105262
    [Google Scholar]
  12. ZhangB. WuX. ZhangX. SunY. YanY. ShiH. ZhuY. WuL. PanZ. ZhuW. QianH. XuW. Human umbilical cord mesenchymal stem cell exosomes enhance angiogenesis through the Wnt4/β-catenin pathway.Stem Cells Transl. Med.20154551352210.5966/sctm.2014‑026725824139
    [Google Scholar]
  13. ZhangB. WangM. GongA. ZhangX. WuX. ZhuY. ShiH. WuL. ZhuW. QianH. XuW. HucMSC-exosome mediated-wnt4 signaling is required for cutaneous wound healing.Stem Cells20153372158216810.1002/stem.177124964196
    [Google Scholar]
  14. AkersJ.C. RamakrishnanV. KimR. SkogJ. NakanoI. PingleS. KalininaJ. HuaW. KesariS. MaoY. BreakefieldX.O. HochbergF.H. Van MeirE.G. CarterB.S. ChenC.C. MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): A platform for glioblastoma biomarker development.PLoS One2013810e7811510.1371/journal.pone.007811524205116
    [Google Scholar]
  15. van NielG. ThéryC. Extracellular vesicles: Eat glutamine and spit acidic bubbles.EMBO J.20203916e10511910.15252/embj.202010511932809264
    [Google Scholar]
  16. ZhangY. LiuY. LiuH. TangW.H. Exosomes: Biogenesis, biologic function and clinical potential.Cell Biosci.2019911910.1186/s13578‑019‑0282‑230815248
    [Google Scholar]
  17. KowalJ. TkachM. ThéryC. Biogenesis and secretion of exosomes.Curr. Opin. Cell Biol.20142911612510.1016/j.ceb.2014.05.00424959705
    [Google Scholar]
  18. FengY. ZhongM. ZengS. WangL. LiuP. XiaoX. LiuY. Exosome-derived miRNAs as predictive biomarkers for diffuse large B-cell lymphoma chemotherapy resistance.Epigenomics2019111355110.2217/epi‑2018‑012330211623
    [Google Scholar]
  19. RoehleA. HoefigK.P. RepsilberD. ThornsC. ZiepertM. WescheK.O. ThiereM. LoefflerM. KlapperW. PfreundschuhM. MatolcsyA. BerndH.W. ReinigerL. MerzH. FellerA.C. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas.Br. J. Haematol.2008142573274410.1111/j.1365‑2141.2008.07237.x18537969
    [Google Scholar]
  20. LawrieC.H. GalS. DunlopH.M. PushkaranB. LigginsA.P. PulfordK. BanhamA.H. PezzellaF. BoultwoodJ. WainscoatJ.S. HattonC.S.R. HarrisA.L. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.Br. J. Haematol.2008141567267510.1111/j.1365‑2141.2008.07077.x18318758
    [Google Scholar]
  21. JiM. RaoE. RamachandrareddyH. ShenY. JiangC. ChenJ. HuY. RizzinoA. ChanW.C. FuK. McKeithanT.W. The miR-17-92 microRNA cluster is regulated by multiple mechanisms in B-cell malignancies.Am. J. Pathol.201117941645165610.1016/j.ajpath.2011.06.00821806958
    [Google Scholar]
  22. CarvalhoA.S. BaetaH. HenriquesA.F.A. EjtehadifarM. TranfieldE.M. SousaA.L. FarinhoA. SilvaB.C. CabeçadasJ. GameiroP. SilvaM.G. BeckH.C. MatthiesenR. Proteomic landscape of extracellular vesicles for diffuse large B-cell lymphoma subtyping.Int. J. Mol. Sci.202122201100410.3390/ijms22201100434681663
    [Google Scholar]
  23. DiC. JiangY. LiM. JuanX. XuC. Circulating exosomal microrna signature as a noninvasive biomarker for diagnosis of diffuse large B-cell lymphoma.Blood2018132Suppl. 15406540610.1182/blood‑2018‑99‑115940
    [Google Scholar]
  24. van EijndhovenM.A.J. ZijlstraJ.M. GroenewegenN.J. DreesE.E.E. van NieleS. BaglioS.R. Koppers-LalicD. van der VoornH. LibregtsS.F.W.M. WaubenM.H.M. de MenezesR.X. van WeeringJ.R.T. NieuwlandR. VisserL. van den BergA. de JongD. PegtelD.M. Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients.JCI Insight2016119e8963110.1172/jci.insight.8963127882350
    [Google Scholar]
  25. AharonA. Rebibo-SabbahA. TzoranI. LevinC. Extracellular vesicles in hematological disorders.Rambam Maimonides Med. J.201454e003210.5041/RMMJ.1016625386348
    [Google Scholar]
  26. DiehlP. FrickeA. SanderL. StammJ. BasslerN. HtunN. ZiemannM. HelbingT. El-OstaA. JowettJ.B.M. PeterK. Microparticles: Major transport vehicles for distinct microRNAs in circulation.Cardiovasc. Res.201293463364410.1093/cvr/cvs00722258631
    [Google Scholar]
  27. RutherfordS.C. FachelA.A. LiS. SawhS. MuleyA. IshiiJ. SaxenaA. DominguezP.M. Caldas LopesE. AgirreX. ChambweN. CorreaF. JiangY. RichardsK.L. BetelD. ShaknovichR. Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations.Blood20181327e13e2310.1182/blood‑2017‑12‑82184329967128
    [Google Scholar]
  28. BachD.H. HongJ.Y. ParkH.J. LeeS.K. The role of exosomes and miRNAs in drug-resistance of cancer cells.Int. J. Cancer2017141222023010.1002/ijc.3066928240776
    [Google Scholar]
  29. TroppanK. WenzlK. DeutschA. LingH. NeumeisterP. PichlerM. MicroRNAs in diffuse large B-cell lymphoma: Implications for pathogenesis, diagnosis, prognosis and therapy.Anticancer Res.201434255756424510984
    [Google Scholar]
  30. YuanW.X. GuiY.X. NaW.N. ChaoJ. YangX. Circulating microRNA-125b and microRNA-130a expression profiles predict chemoresistance to R-CHOP in diffuse large B-cell lymphoma patients.Oncol. Lett.201611142343210.3892/ol.2015.386626870228
    [Google Scholar]
  31. KimS.W. RamasamyK. BouamarH. LinA.P. JiangD. AguiarR.C.T. MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 ( TNFAIP3, A20 ).Proc. Natl. Acad. Sci. USA2012109207865787010.1073/pnas.120008110922550173
    [Google Scholar]
  32. DueH. SvendsenP. BødkerJ.S. SchmitzA. BøgstedM. JohnsenH.E. El-GalalyT.C. RougA.S. DybkærK. miR-155 as a biomarker in B-Cell malignancies.BioMed Res. Int.2016201611410.1155/2016/951303727294145
    [Google Scholar]
  33. Lopez-SantillanM. Larrabeiti-EtxebarriaA. Arzuaga-MendezJ. Lopez-LopezE. Garcia-OradA. Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: A systematic review.Oncotarget2018932228502286110.18632/oncotarget.2523029854319
    [Google Scholar]
  34. AlencarA.J. MalumbresR. KozloskiG.A. AdvaniR. TalrejaN. ChinichianS. BrionesJ. NatkunamY. SehnL.H. GascoyneR.D. TibshiraniR. LossosI.S. MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.Clin. Cancer Res.201117124125413510.1158/1078‑0432.CCR‑11‑022421525173
    [Google Scholar]
  35. FilipA.A. GrendaA. PopekS. KoczkodajD. Michalak-WojnowskaM. BudzyńskiM. Wąsik-SzczepanekE. ZmorzyńskiS. KarczmarczykA. GiannopoulosK. Expression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL—another piece in the puzzle.Ann. Hematol.2017961335010.1007/s00277‑016‑2840‑627730344
    [Google Scholar]
  36. BrownP.J. AsheS.L. LeichE. BurekC. BarransS. FentonJ.A. JackA.S. PulfordK. RosenwaldA. BanhamA.H. Potentially oncogenic B-cell activation–induced smaller isoforms of FOXP1 are highly expressed in the activated B cell–like subtype of DLBCL.Blood200811152816282410.1182/blood‑2007‑09‑11511318077790
    [Google Scholar]
  37. BanhamA.H. ConnorsJ.M. BrownP.J. CordellJ.L. OttG. SreenivasanG. FarinhaP. HorsmanD.E. GascoyneR.D. Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma.Clin. Cancer Res.20051131065107210.1158/1078‑0432.1065.11.315709173
    [Google Scholar]
  38. GascoyneD.M. BanhamA.H. The significance of FOXP1 in diffuse large B-cell lymphoma.Leuk. Lymphoma20175851037105110.1080/10428194.2016.122893227678023
    [Google Scholar]
  39. YuB. ZhouX. LiB. XiaoX. YanS. ShiD. FOXP1 expression and its clinicopathologic significance in nodal and extranodal diffuse large B-cell lymphoma.Ann. Hematol.201190670170810.1007/s00277‑010‑1124‑921120478
    [Google Scholar]
  40. CaoD. JiangY. FengY. JingC.X. XuJ. XuC.G. The value of circulating exsomal miR-451a to monitor therapy response in diffuse large B cell lymphoma.Sichuan Da Xue Xue Bao Yi Xue Ban201849339940330014642
    [Google Scholar]
  41. ChenZ. YouL. WangL. HuangX. LiuH. WeiJ. ZhuL. QianW. Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo.J. Exp. Clin. Cancer Res.201837119010.1186/s13046‑018‑0863‑730103789
    [Google Scholar]
  42. KochR. DemantM. AungT. DieringN. CicholasA. ChapuyB. WenzelD. LahmannM. GüntschA. KieckeC. BeckerS. HupfeldT. VenkataramaniV. ZiepertM. OpitzL. KlapperW. TrümperL. WulfG.G. Populational equilibrium through exosome-mediated Wnt signaling in tumor progression of diffuse large B-cell lymphoma.Blood2014123142189219810.1182/blood‑2013‑08‑52388624563408
    [Google Scholar]
  43. KochR. AungT. VogelD. ChapuyB. WenzelD. BeckerS. SinzigU. VenkataramaniV. von MachT. JacobR. TruemperL. WulfG.G. Nuclear trapping through inhibition of exosomal export by indomethacin increases cytostatic efficacy of doxorubicin and pixantrone.Clin. Cancer Res.201622239540410.1158/1078‑0432.CCR‑15‑057726369630
    [Google Scholar]
  44. AungT. ChapuyB. VogelD. WenzelD. OppermannM. LahmannM. WeinhageT. MenckK. HupfeldT. KochR. TrümperL. WulfG.G. Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3.Proc. Natl. Acad. Sci. USA201110837153361534110.1073/pnas.110285510821873242
    [Google Scholar]
/content/journals/chr/10.2174/011570162X288575240821201433
Loading
/content/journals/chr/10.2174/011570162X288575240821201433
Loading

Data & Media loading...


  • Article Type:
    Review Article
Keyword(s): Biomarkers; DLBCL; EVs; exosomes; HIV; microRNA
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test